281 related articles for article (PubMed ID: 29446748)
1. Anti-Oxidants as Chemopreventive Agents in Prostate Cancer: A Gap Between Preclinical and Clinical Studies.
Mohsenzadegan M; Seif F; Farajollahi MM; Khoshmirsafa M
Recent Pat Anticancer Drug Discov; 2018; 13(2):224-239. PubMed ID: 29446748
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress and cyclooxygenase activity in prostate carcinogenesis: targets for chemopreventive strategies.
Pathak SK; Sharma RA; Steward WP; Mellon JK; Griffiths TR; Gescher AJ
Eur J Cancer; 2005 Jan; 41(1):61-70. PubMed ID: 15617991
[TBL] [Abstract][Full Text] [Related]
3. Identification of organoselenium compounds that possess chemopreventive properties in human prostate cancer LNCaP cells.
Terazawa R; Garud DR; Hamada N; Fujita Y; Itoh T; Nozawa Y; Nakane K; Deguchi T; Koketsu M; Ito M
Bioorg Med Chem; 2010 Oct; 18(19):7001-8. PubMed ID: 20805033
[TBL] [Abstract][Full Text] [Related]
4. Role of oxidative stress response elements and antioxidants in prostate cancer pathobiology and chemoprevention--a mechanistic approach.
Sikka SC
Curr Med Chem; 2003 Dec; 10(24):2679-92. PubMed ID: 14529458
[TBL] [Abstract][Full Text] [Related]
5. Antioxidants for prostate cancer chemoprevention: challenges and opportunities.
Thapa D; Ghosh R
Biochem Pharmacol; 2012 May; 83(10):1319-30. PubMed ID: 22248733
[TBL] [Abstract][Full Text] [Related]
6. Anti-oxidants from green tea and pomegranate for chemoprevention of prostate cancer.
Adhami VM; Mukhtar H
Mol Biotechnol; 2007 Sep; 37(1):52-7. PubMed ID: 17914164
[TBL] [Abstract][Full Text] [Related]
7. Can we prevent prostate cancer? Rationale and current status of prostate cancer chemoprevention.
Fujimoto N; Chang C; Nomura M; Matsumoto T
Urol Int; 2005; 74(4):289-97. PubMed ID: 15897691
[TBL] [Abstract][Full Text] [Related]
8. A prooxidant mechanism for the anticancer and chemopreventive properties of plant polyphenols.
Khan HY; Zubair H; Ullah MF; Ahmad A; Hadi SM
Curr Drug Targets; 2012 Dec; 13(14):1738-49. PubMed ID: 23140285
[TBL] [Abstract][Full Text] [Related]
9. Chemoprevention of prostate cancer by diet-derived antioxidant agents and hormonal manipulation (Review).
Pathak SK; Sharma RA; Mellon JK
Int J Oncol; 2003 Jan; 22(1):5-13. PubMed ID: 12469179
[TBL] [Abstract][Full Text] [Related]
10. Current and future status of prostate cancer chemoprevention.
Fujimoto N; Nomura M; Matsumoto T
Expert Rev Anticancer Ther; 2006 Jan; 6(1):59-71. PubMed ID: 16375645
[TBL] [Abstract][Full Text] [Related]
11. Reactive oxygen species in redox cancer therapy.
Tong L; Chuang CC; Wu S; Zuo L
Cancer Lett; 2015 Oct; 367(1):18-25. PubMed ID: 26187782
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer chemoprevention by natural agents: Clinical evidence and potential implications.
Chhabra G; Singh CK; Ndiaye MA; Fedorowicz S; Molot A; Ahmad N
Cancer Lett; 2018 May; 422():9-18. PubMed ID: 29471004
[TBL] [Abstract][Full Text] [Related]
13. Antioxidant dietary supplements: Rationale and current status as chemopreventive agents for prostate cancer.
Fleshner NE; Kucuk O
Urology; 2001 Apr; 57(4 Suppl 1):90-4. PubMed ID: 11295603
[TBL] [Abstract][Full Text] [Related]
14. Cancer chemoprevention: selenium as a prooxidant, not an antioxidant.
Drake EN
Med Hypotheses; 2006; 67(2):318-22. PubMed ID: 16574336
[TBL] [Abstract][Full Text] [Related]
15. Phase III prostate cancer chemoprevention trials.
Parnes HL; Brawley OW; Minasian LM; Ford LG
Recent Results Cancer Res; 2014; 202():73-7. PubMed ID: 24531780
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of disease: Prostate cancer--a model for cancer chemoprevention in clinical practice.
Canby-Hagino ED; Thompson IM
Nat Clin Pract Oncol; 2005 May; 2(5):255-61. PubMed ID: 16264961
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress in prostate cancer: changing research concepts towards a novel paradigm for prevention and therapeutics.
Paschos A; Pandya R; Duivenvoorden WC; Pinthus JH
Prostate Cancer Prostatic Dis; 2013 Sep; 16(3):217-25. PubMed ID: 23670256
[TBL] [Abstract][Full Text] [Related]
18. Anthocyans as tertiary chemopreventive agents in bladder cancer: anti-oxidant mechanisms and interaction with mitomycin C.
Higgins JA; Zainol M; Brown K; Jones GD
Mutagenesis; 2014 Jul; 29(4):227-35. PubMed ID: 24743948
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress in chemoprevention trials.
DeWeese TL; Hruszkewycz AM; Marnett LJ
Urology; 2001 Apr; 57(4 Suppl 1):137-40. PubMed ID: 11295612
[TBL] [Abstract][Full Text] [Related]
20. Pro-oxidant activity of polyphenols and its implication on cancer chemoprevention and chemotherapy.
León-González AJ; Auger C; Schini-Kerth VB
Biochem Pharmacol; 2015 Dec; 98(3):371-80. PubMed ID: 26206193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
